Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis

Deguan Lv, Hening Li, and Linxi Chen

Acta Biochim Biophys Sin (Shanghai) 2013,Jul;45(7): 527–533; doi: 10.1093/abbs/gmt040

Institute of Pharmacy and Pharmacology, University of South China, Hengyang 421001, China

Apelin is a bioactive peptide discovered recently that has been proved to be an endogenous ligand of the APJ receptor. Apelin and APJ are widely distributed in the central nervous system and peripheral tissues. Researches have confirmed that apelin/APJ involved in a wide range of physiological and pathological functions in the cardiovascular system. Investigations indicated that apelin is anovelcriticalfactor in the development of atherosclerosis (AS). In this review, we discuss the roles of apelin in the vascular smooth muscle cell proliferation, monocytes-endothelial cell adhesion, and angiogenesis that potentially reveals a new cellular mechanism of AS. Considering these roles, apelin and APJ may be noveltherapeutic targets of AS.

图例: apelin/APJ胞内信号转导对血管平滑肌细胞生长的影响

引用本文的论文:

全文: http://abbs.oxfordjournals.org/content/45/7/527.full